Mineralys Therapeutics Set to Release Q4 and Full-Year 2023 Financial Results, Eyes on Future Growth Prospects
RADNOR, PA — Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a prominent name in the therapeutic industry, has announced plans to release its financial results for the fourth quarter and full year …
Mineralys Therapeutics Set to Release Q4 and Full-Year 2023 Financial Results, Eyes on Future Growth Prospects Read More